As of 2025-07-03, the Fair Value of Anavex Life Sciences Corp (AVXL) is -2.76 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.57 USD, the upside of Anavex Life Sciences Corp is -126.12%.
With the market price of 10.57 USD and our fair value calculation, Anavex Life Sciences Corp (AVXL) is not a good investment. Investing in Anavex stocks now will result in a potential loss of 126.12%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | -26.28 | -37.91 | -47.98 | -47.51 | -43.00 | -40.54 |
| YoY growth | 0.04% | -44.25% | -26.56% | 0.98% | 9.49% | -12.06% |
| Market Cap (mil) | 902.36 |
| P/E | |
| Forward P/E |
| EPS | -0.55 |
| Avg earnings growth rate | -12.06% |
| TTM earnings | -47.14 |